by European Alliance | Sep 9, 2021 | News
Transparency of clinical trials and good governance should be included in the EMA extended mandate Brussels, 9 September 2021 In occasion of the ongoing trilogues on the European Medicines Agency (EMA) extended mandate, Members of the European Alliance for...
by European Alliance | Aug 26, 2021 | News
Brussels, 26 August 2021 As of end of June 2021, Rosa Castro is the new Manager of the European Alliance for responsible R&D and Affordable Medicines, which is hosted by EPHA. Rosa brings her experience working at the intersection of science policy and...
by European Alliance | Feb 23, 2021 | News
The European Commission launched a public consultation on an inception impact assessment for the future European Health Emergency Preparedness and Response Authority – HERA. At this link and below, the Alliance response to the consultation. Download the feedback...
by European Alliance | Jul 13, 2020 | News
Download the joint position paper The EU must ensure access to affordable and quality medicines in Europe whilst guaranteeing everyone’s right to a healthy and sustainable environment. Human medicine is not an ordinary commodity – public interest and public health...
by European Alliance | Jun 25, 2020 | News
The Access to COVID-19 Tools Accelerator (ACT-A) was launched by the World Health Organization (WHO), governments and global health actors as an ‘unprecedented and inclusive partnership’ to address some of the challenges linked with the management of the COVID-19...
by European Alliance | May 4, 2020 | News
Download the full statement Concrete actions needed for global pledges to result in access for all 4th May 2020 We welcome the efforts of the global health actors and other stakeholders to rally financial support to the research and development (R&D),...
